FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 351:2599-2610 December 16, 2004 Number 25 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

ABSTRACT

Background Few studies have simultaneously investigated the role of soluble tumor necrosis factor (TNF-) receptors types 1 and 2 (sTNF-R1 and sTNF-R2), C-reactive protein, and interleukin-6 as predictors of cardiovascular events. The value of these inflammatory markers as independent predictors remains controversial.

Methods We examined plasma levels of sTNF-R1, sTNF-R2, interleukin-6, and C-reactive protein as markers of risk for coronary heart disease among women participating in the Nurses' Health Study and men participating in the Health Professionals Follow-up Study in nested case–control analyses. Among participants who provided a blood sample and who were free of cardiovascular disease at baseline, 239 women and 265 men had a nonfatal myocardial infarction or fatal coronary heart disease during eight years and six years of follow-up, respectively. Using risk-set sampling, we selected controls in a 2:1 ratio with matching for age, smoking status, and date of blood sampling.

Results After adjustment for matching factors, high levels of interleukin-6 and C-reactive protein were significantly related to an increased risk of coronary heart disease in both sexes, whereas high levels of soluble TNF- receptors were significant only among women. Further adjustment for lipid and nonlipid factors attenuated all associations; only C-reactive protein levels remained significant. The relative risk among all participants was 1.79 for those with C-reactive protein levels of at least 3.0 mg per liter, as compared with those with levels of less than 1.0 mg per liter (95 percent confidence interval, 1.27 to 2.51; P for trend <0.001). Additional adjustment for the presence or absence of diabetes and hypertension moderately attenuated the relative risk to 1.68 (95 percent confidence interval, 1.18 to 2.38; P for trend = 0.008).

Conclusions Elevated levels of inflammatory markers, particularly C-reactive protein, indicate an increased risk of coronary heart disease. Although plasma lipid levels were more strongly associated with an increased risk than were inflammatory markers, the level of C-reactive protein remained a significant contributor to the prediction of coronary heart disease.

Source Information

From the Departments of Epidemiology (J.K.P., T.P., J.E.M., S.E.H., K.J., G.C.C., M.J.S., E.B.R.) and Nutrition (T.P., M.J.S., E.B.R.), Harvard School of Public Health; the Division of Preventive Medicine (J.K.P., J.E.M.) and Channing Laboratory (T.P., J.M., S.E.H., G.C.C., M.J.S., E.B.R.), Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; the Department of Oral Health Policy and Epidemiology, Harvard School of Dental Medicine (K.J.); the Department of Laboratory Medicine, Children's Hospital (N.R.); and the Department of Pathology, Harvard Medical School (N.R.) — all in Boston; the Department of Epidemiology, German Institute of Human Nutrition, Potsdam-Rehbruecke, Germany (T.P.); and Merck Research Laboratories, West Point, Pa. (C.C.C.).

Ms. Pai and Dr. Pischon contributed equally to this article.

Address reprint requests to Dr. Rimm at the Departments of Epidemiology and Nutrition, Harvard School of Public Health, 665 Huntington Ave., Boston, MA 02115, or at erimm{at}hsph.harvard.edu.

Full Text of this Article

This article has been cited by other articles:

• Currie, C J, Poole, C D, Conway, P (2008). Evaluation of the association between the first observation and the longitudinal change in C-reactive protein, and all-cause mortality. Heart 94: 457-462 [Abstract] [Full Text]  
• Zhang, S. M., Ridker, P. M. (2008). Response: Re: C-Reactive Protein and Risk of Breast Cancer. JNCI J Natl Cancer Inst 100: 444-445 [Full Text]  
• Clarke, R., Emberson, J. R., Breeze, E., Casas, J. P., Parish, S., Hingorani, A. D., Fletcher, A., Collins, R., Smeeth, L. (2008). Biomarkers of inflammation predict both vascular and non-vascular mortality in older men. Eur Heart J 29: 800-809 [Abstract] [Full Text]  
• Fabbri, L. M., Luppi, F., Beghe, B., Rabe, K. F. (2008). Complex chronic comorbidities of COPD. Eur Respir J 31: 204-212 [Abstract] [Full Text]  
• Packard, R. R. S., Libby, P. (2008). Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction. Clin. Chem. 54: 24-38 [Abstract] [Full Text]  
• Chen, H., O'Reilly, E. J., Schwarzschild, M. A., Ascherio, A. (2008). Peripheral Inflammatory Biomarkers and Risk of Parkinson's Disease. Am J Epidemiol 167: 90-95 [Abstract] [Full Text]  
• Otter, W., Winter, M., Doering, W., Standl, E., Schnell, O. (2007). C-Reactive Protein in Diabetic and Nondiabetic Patients With Acute Myocardial Infarction. Diabetes Care 30: 3080-3082 [Full Text]  
• Eskandari, F., Martinez, P. E., Torvik, S., Phillips, T. M., Sternberg, E. M., Mistry, S., Ronsaville, D., Wesley, R., Toomey, C., Sebring, N. G., Reynolds, J. C., Blackman, M. R., Calis, K. A., Gold, P. W., Cizza, G., for the Premenopausal, Osteoporosis Women, Alendro, (2007). Low Bone Mass in Premenopausal Women With Depression. Arch Intern Med 167: 2329-2336 [Abstract] [Full Text]  
• Spagnoli, L. G., Bonanno, E., Sangiorgi, G., Mauriello, A. (2007). Role of Inflammation in Atherosclerosis. JNM 48: 1800-1815 [Abstract] [Full Text]  
• Kato, S., Lindholm, B., Axelsson, J., Qureshi, R. A., Barany, P., Heimburger, O., Gustafsson, J.-A., Stenvinkel, P., Nordfors, L. (2007). Association between oestrogen receptor {alpha} gene polymorphism and mortality in female end-stage renal disease patients. Nephrol Dial Transplant 22: 2571-2577 [Abstract] [Full Text]  
• Allayee, H., Hartiala, J., Lee, W., Mehrabian, M., Irvin, C. G., Conti, D. V., Lima, J. J. (2007). The Effect of Montelukast and Low-Dose Theophylline on Cardiovascular Disease Risk Factors in Asthmatics. Chest 132: 868-874 [Abstract] [Full Text]  
• Moran, L. J., Noakes, M., Clifton, P. M., Wittert, G. A., Belobrajdic, D. P., Norman, R. J. (2007). C-Reactive Protein before and after Weight Loss in Overweight Women with and without Polycystic Ovary Syndrome. J. Clin. Endocrinol. Metab. 92: 2944-2951 [Abstract] [Full Text]  
• Stockley, R A (2007). Biomarkers in COPD: time for a deep breath. Thorax 62: 657-660 [Full Text]  
• Yeung, D.C.Y., Xu, A., Cheung, C.W.S., Wat, N.M.S., Yau, M.H., Fong, C.H.Y., Chau, M.T., Lam, K.S.L. (2007). Serum Adipocyte Fatty Acid-Binding Protein Levels Were Independently Associated With Carotid Atherosclerosis. Arterioscler. Thromb. Vasc. Bio. 27: 1796-1802 [Abstract] [Full Text]  
• Rohde, E., Bartmann, C., Schallmoser, K., Reinisch, A., Lanzer, G., Linkesch, W., Guelly, C., Strunk, D. (2007). Immune Cells Mimic the Morphology of Endothelial Progenitor Colonies In Vitro. Stem Cells 25: 1746-1752 [Abstract] [Full Text]  
• Celli, B. R., Barnes, P. J. (2007). Exacerbations of chronic obstructive pulmonary disease. Eur Respir J 29: 1224-1238 [Abstract] [Full Text]  
• Pai, J. K., Manson, J. E., Rexrode, K. M., Albert, C. M., Hunter, D. J., Rimm, E. B. (2007). Complement factor H (Y402H) polymorphism and risk of coronary heart disease in US men and women. Eur Heart J 28: 1297-1303 [Abstract] [Full Text]  
• Ridker, P. M. (2007). C-Reactive Protein and the Prediction of Cardiovascular Events Among Those at Intermediate Risk: Moving an Inflammatory Hypothesis Toward Consensus. J Am Coll Cardiol 49: 2129-2138 [Abstract] [Full Text]  
• Flynn, M. G., McFarlin, B. K., Markofski, M. M. (2007). State of the Art Reviews: The Anti-Inflammatory Actions of Exercise Training. AMERICAN JOURNAL OF LIFESTYLE MEDICINE 1: 220-235 [Abstract]  
• Pischon, N., Heng, N., Bernimoulin, J.-P., Kleber, B.-M., Willich, S.N., Pischon, T. (2007). Obesity, Inflammation, and Periodontal Disease. J. Dent. Res. 86: 400-409 [Abstract] [Full Text]  
• Apple, F. S., Pearce, L. A., Chung, A., Ler, R., Murakami, M. M. (2007). Multiple Biomarker Use for Detection of Adverse Events in Patients Presenting with Symptoms Suggestive of Acute Coronary Syndrome. Clin. Chem. 53: 874-881 [Abstract] [Full Text]  
• Esteve, E., Castro, A., Lopez-Bermejo, A., Vendrell, J., Ricart, W., Fernandez-Real, J.-M. (2007). Serum Interleukin-6 Correlates With Endothelial Dysfunction in Healthy Men Independently of Insulin Sensitivity. Diabetes Care 30: 939-945 [Abstract] [Full Text]  
• Dullaart, R. P F, de Vries, R., van Tol, A., Sluiter, W. J (2007). Lower plasma adiponectin is a marker of increased intima-media thickness associated with type 2 diabetes mellitus and with male gender. Eur J Endocrinol 156: 387-394 [Abstract] [Full Text]  
• Sattar, N., Murray, H. M., McConnachie, A., Blauw, G. J., Bollen, E. L.E.M., Buckley, B. M., Cobbe, S. M., Ford, I., Gaw, A., Hyland, M., Jukema, J. W., Kamper, A. M., Macfarlane, P. W., Murphy, M. B., Packard, C. J., Perry, I. J., Stott, D. J., Sweeney, B. J., Twomey, C., Westendorp, R. G.J., Shepherd, J., for the PROSPER Study Group, (2007). C-Reactive Protein and Prediction of Coronary Heart Disease and Global Vascular Events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). Circulation 115: 981-989 [Abstract] [Full Text]  
• Niu, J., Azfer, A., Rogers, L. M., Wang, X., Kolattukudy, P. E. (2007). Cardioprotective effects of cerium oxide nanoparticles in a transgenic murine model of cardiomyopathy. Cardiovasc Res 73: 549-559 [Abstract] [Full Text]  
• Everett, B. M., Kurth, T., Buring, J. E., Ridker, P. M. (2006). The Relative Strength of C-Reactive Protein and Lipid Levels as Determinants of Ischemic Stroke Compared With Coronary Heart Disease in Women. J Am Coll Cardiol 48: 2235-2242 [Abstract] [Full Text]  
• Sinning, J.-M., Bickel, C., Messow, C.-M., Schnabel, R., Lubos, E., Rupprecht, H. J., Espinola-Klein, C., Lackner, K. J., Tiret, L., Munzel, T., Blankenberg, S., for the Athero Gene Investigators, (2006). Impact of C-reactive protein and fibrinogen on cardiovascular prognosis in patients with stable angina pectoris: the AtheroGene study. Eur Heart J 27: 2962-2968 [Abstract] [Full Text]  
• DIAMANTI-KANDARAKIS, E., PATERAKIS, T., KANDARAKIS, H. A. (2006). Indices of Low-Grade Inflammation in Polycystic Ovary Syndrome. Ann. N. Y. Acad. Sci. 1092: 175-186 [Abstract] [Full Text]  
• Marcantonio, E. R., Rudolph, J. L., Culley, D., Crosby, G., Alsop, D., Inouye, S. K. (2006). Review Article: Serum Biomarkers for Delirium. J. Gerontol. A Biol. Sci. Med. Sci. 61: 1281-1286 [Abstract] [Full Text]  
• Libby, P., Ridker, P. M. (2006). Inflammation and Atherothrombosis: From Population Biology and Bench Research to Clinical Practice. J Am Coll Cardiol 48: A33-A46 [Abstract] [Full Text]  
• Blankenberg, S., Yusuf, S. (2006). The inflammatory hypothesis: any progress in risk stratification and therapeutic targets?. Circulation 114: 1557-1560 [Full Text]  
• Bos, M. J., Schipper, C. M. A., Koudstaal, P. J., Witteman, J. C.M., Hofman, A., Breteler, M. M.B. (2006). High Serum C-Reactive Protein Level Is Not an Independent Predictor for Stroke: The Rotterdam Study. Circulation 114: 1591-1598 [Abstract] [Full Text]  
• Lopez-Garcia, E., van Dam, R. M, Qi, L., Hu, F. B (2006). Coffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women.. Am. J. Clin. Nutr. 84: 888-893 [Abstract] [Full Text]  
• Schwarze, P E, Ovrevik, J, Lag, M, Refsnes, M, Nafstad, P, Hetland, R B, Dybing, E (2006). Particulate matter properties and health effects: consistency of epidemiological and toxicological studies. Hum Exp Toxicol 25: 559-579 [Abstract]  
• Yin, Y., Dalal, D., Dong, J. (2006). Anti-inflammatory effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: potential benefits for the prevention of atrial fibrillation: reply. Eur Heart J 27: 2371-2371 [Full Text]  
• Wu, T., Willett, W. C., Rifai, N., Shai, I., Manson, J. E., Rimm, E. B. (2006). Is Plasma Oxidized Low-Density Lipoprotein, Measured With the Widely Used Antibody 4E6, an Independent Predictor of Coronary Heart Disease Among U.S. Men and Women?. J Am Coll Cardiol 48: 973-979 [Abstract] [Full Text]  
• Figaro, M. K., Kritchevsky, S. B., Resnick, H. E., Shorr, R. I., Butler, J., Shintani, A., Penninx, B. W., Simonsick, E. M., Goodpaster, B. H., Newman, A. B., Schwartz, A. V., Harris, T. B., for the Health Aging and Body Composition study, (2006). Diabetes, Inflammation, and Functional Decline in Older Adults: Findings from the Health, Aging and Body Composition (ABC) study.. Diabetes Care 29: 2039-2045 [Abstract] [Full Text]  
• Albert, M. A., Ridker, P. M (2006). C-Reactive Protein as a Risk Predictor: Do Race/Ethnicity and Gender Make a Difference?. Circulation 114: e67-e74 [Full Text]  
• Kistorp, C. (2006). Risk Stratification in Secondary Prevention: Advances in Multimarker Profiles, or Back to Basics?. Circulation 114: 184-186 [Full Text]  
• Blankenberg, S., McQueen, M. J., Smieja, M., Pogue, J., Balion, C., Lonn, E., Rupprecht, H. J., Bickel, C., Tiret, L., Cambien, F., Gerstein, H., Munzel, T., Yusuf, S., for the HOPE Study Investigators, (2006). Comparative Impact of Multiple Biomarkers and N-Terminal Pro-Brain Natriuretic Peptide in the Context of Conventional Risk Factors for the Prediction of Recurrent Cardiovascular Events in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation 114: 201-208 [Abstract] [Full Text]  
• Lloyd-Jones, D. M., Liu, K., Tian, L., Greenland, P. (2006). Narrative Review: Assessment of C-Reactive Protein in Risk Prediction for Cardiovascular Disease. ANN INTERN MED 145: 35-42 [Abstract] [Full Text]  
• Cook, N. R., Buring, J. E., Ridker, P. M (2006). The Effect of Including C-Reactive Protein in Cardiovascular Risk Prediction Models for Women. ANN INTERN MED 145: 21-29 [Abstract] [Full Text]  
• Wang, M., Tsai, B. M., Crisostomo, P. R., Meldrum, D. R. (2006). Tumor Necrosis Factor Receptor 1 Signaling Resistance in the Female Myocardium During Ischemia. Circulation 114: I-282-I-289 [Abstract] [Full Text]  
• Tanne, D., Benderly, M., Goldbourt, U., Haim, M., Tenenbaum, A., Fisman, E. Z., Matas, Z., Adler, Y., Zimmlichman, R., Behar, S. (2006). C-Reactive Protein as a Predictor of Incident Ischemic Stroke Among Patients With Preexisting Cardiovascular Disease. Stroke 37: 1720-1724 [Abstract] [Full Text]  
• Langenberg, C., Bergstrom, J., Scheidt-Nave, C., Pfeilschifter, J., Barrett-Connor, E. (2006). Cardiovascular Death and the Metabolic Syndrome: Role of adiposity-signaling hormones and inflammatory markers.. Diabetes Care 29: 1363-1369 [Abstract] [Full Text]  
• Yoshida, T., Kaneshi, T., Shimabukuro, T., Sunagawa, M., Ohta, T. (2006). Serum C-Reactive Protein and Its Relation to Cardiovascular Risk Factors and Adipocytokines in Japanese Children. J. Clin. Endocrinol. Metab. 91: 2133-2137 [Abstract] [Full Text]  
• Diamanti-Kandarakis, E., Paterakis, T., Alexandraki, K., Piperi, C., Aessopos, A., Katsikis, I., Katsilambros, N., Kreatsas, G., Panidis, D. (2006). Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin. Hum Reprod 21: 1426-1431 [Abstract] [Full Text]  
• Vasan, R. S. (2006). Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations. Circulation 113: 2335-2362 [Full Text]  
• Tuncman, G., Erbay, E., Hom, X., De Vivo, I., Campos, H., Rimm, E. B., Hotamisligil, G. S. (2006). A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease. Proc. Natl. Acad. Sci. USA 103: 6970-6975 [Abstract] [Full Text]  
• Scirica, B. M., Morrow, D. A., Verma, S., Devaraj, S., Jialal, I., Scirica, B. M., Morrow, D. A., Verma, S., Devaraj, S., Jialal, I. (2006). The Verdict Is Still Out. Circulation 113: 2128-2151 [Full Text]  
• von Eynatten, M., Hamann, A., Twardella, D., Nawroth, P. P., Brenner, H., Rothenbacher, D. (2006). Relationship of Adiponectin with Markers of Systemic Inflammation, Atherogenic Dyslipidemia, and Heart Failure in Patients with Coronary Heart Disease. Clin. Chem. 52: 853-859 [Abstract] [Full Text]  
• Tsimikas, S., Willerson, J. T., Ridker, P. M. (2006). C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients.. J Am Coll Cardiol 47: C19-C31 [Abstract] [Full Text]  
• Koh, K. K., Yoon, B.-K. (2006). Controversies regarding hormone therapy: Insights from inflammation and hemostasis. Cardiovasc Res 70: 22-30 [Abstract] [Full Text]  
• Stross, C., Radtke, S., Clahsen, T., Gerlach, C., Volkmer-Engert, R., Schaper, F., Heinrich, P. C., Hermanns, H. M. (2006). Oncostatin M Receptor-mediated Signal Transduction Is Negatively Regulated by SOCS3 through a Receptor Tyrosine-independent Mechanism. J. Biol. Chem. 281: 8458-8468 [Abstract] [Full Text]  
• Rogers, M. A. M., Langa, K. M., Kim, C., Nallamothu, B. K., McMahon, L. F. Jr, Malani, P. N., Fries, B. E., Kaufman, S. R., Saint, S. (2006). Contribution of infection to increased mortality in women after cardiac surgery.. Arch Intern Med 166: 437-443 [Abstract] [Full Text]  
• Armstrong, E. J., Morrow, D. A., Sabatine, M. S. (2006). Inflammatory Biomarkers in Acute Coronary Syndromes: Part I: Introduction and Cytokines. Circulation 113: e72-e75 [Full Text]  
• Qi, L., van Dam, R. M., Liu, S., Franz, M., Mantzoros, C., Hu, F. B. (2006). Whole-Grain, Bran, and Cereal Fiber Intakes and Markers of Systemic Inflammation in Diabetic Women. Diabetes Care 29: 207-211 [Abstract] [Full Text]  
• Jiang, R., Jacobs, D. R. Jr., Mayer-Davis, E., Szklo, M., Herrington, D., Jenny, N. S., Kronmal, R., Barr, R. G. (2006). Nut and Seed Consumption and Inflammatory Markers in the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol 163: 222-231 [Abstract] [Full Text]  
• Finch, C. E. (2006). A perspective on sporadic inclusion-body myositis: The role of aging and inflammatory processes. Neurology 66: S1-S6 [Abstract] [Full Text]  
• Gonzalez-Clemente, J M, Gimenez-Perez, G, Richart, C, Broch, M, Caixas, A, Megia, A, Gimenez-Palop, O, Simon, I, Mauricio, D, Vendrell, J (2005). The tumour necrosis factor (TNF)-{alpha} system is activated in accordance with pulse pressure in normotensive subjects with type 1 diabetes mellitus. Eur J Endocrinol 153: 687-691 [Abstract] [Full Text]  
• Ginsburg, G. S., Donahue, M. P., Newby, L. K. (2005). Prospects for Personalized Cardiovascular Medicine: The Impact of Genomics. J Am Coll Cardiol 46: 1615-1627 [Abstract] [Full Text]  
• Mahmud, A., Feely, J. (2005). Arterial Stiffness Is Related to Systemic Inflammation in Essential Hypertension. Hypertension 46: 1118-1122 [Abstract] [Full Text]  
• Mehra, V. C., Ramgolam, V. S., Bender, J. R. (2005). Cytokines and cardiovascular disease. J. Leukoc. Biol. 78: 805-818 [Abstract] [Full Text]  
• Kivimaki, M., Lawlor, D. A., Juonala, M., Davey Smith, G., Elovainio, M., Keltikangas-Jarvinen, L., Vahtera, J., Viikari, J. S.A., Raitakari, O. T. (2005). Lifecourse Socioeconomic Position, C-Reactive Protein, and Carotid Intima-Media Thickness in Young Adults: The Cardiovascular Risk in Young Finns Study. Arterioscler. Thromb. Vasc. Bio. 25: 2197-2202 [Abstract] [Full Text]  
• Mukamal, K. J., Jensen, M. K., Gronbaek, M., Stampfer, M. J., Manson, J. E., Pischon, T., Rimm, E. B. (2005). Drinking Frequency, Mediating Biomarkers, and Risk of Myocardial Infarction in Women and Men. Circulation 112: 1406-1413 [Abstract] [Full Text]  
• Schnabel, R., Blankenberg, S., Lubos, E., Lackner, K. J., Rupprecht, H. J., Espinola-Klein, C., Jachmann, N., Post, F., Peetz, D., Bickel, C., Cambien, F., Tiret, L., Munzel, T. (2005). Asymmetric Dimethylarginine and the Risk of Cardiovascular Events and Death in Patients With Coronary Artery Disease: Results from the AtheroGene Study. Circ. Res. 97: e53-e59 [Abstract] [Full Text]  
• Clearfield, M. B. (2005). C-Reactive Protein: A New Risk Assessment Tool for Cardiovascular Disease. JAOA: Journal of the American Osteopathic Association 105: 409-416 [Abstract] [Full Text]  
• Tiret, L., Godefroy, T., Lubos, E., Nicaud, V., Tregouet, D.-A., Barbaux, S., Schnabel, R., Bickel, C., Espinola-Klein, C., Poirier, O., Perret, C., Munzel, T., Rupprecht, H.-J., Lackner, K., Cambien, F., Blankenberg, S., for the AtheroGene Investigators, (2005). Genetic Analysis of the Interleukin-18 System Highlights the Role of the Interleukin-18 Gene in Cardiovascular Disease. Circulation 112: 643-650 [Abstract] [Full Text]  
• Pischon, T., Pai, J. K., Manson, J. E., Hu, F. B., Rexrode, K. M., Hunter, D., Rimm, E. B. (2005). Peroxisome Proliferator-Activated Receptor-{gamma}2 P12A Polymorphism and Risk of Coronary Heart Disease in US Men and Women. Arterioscler. Thromb. Vasc. Bio. 25: 1654-1658 [Abstract] [Full Text]  
• Zheng, H., Cable, R., Spencer, B., Votto, N., Katz, S. D. (2005). Iron Stores and Vascular Function in Voluntary Blood Donors. Arterioscler. Thromb. Vasc. Bio. 25: 1577-1583 [Abstract] [Full Text]  
• Ridker, P. M, Rifai, N., Cook, N. R., Bradwin, G., Buring, J. E. (2005). Non-HDL Cholesterol, Apolipoproteins A-I and B100, Standard Lipid Measures, Lipid Ratios, and CRP as Risk Factors for Cardiovascular Disease in Women. JAMA 294: 326-333 [Abstract] [Full Text]  
• Karelis, A. D., Faraj, M., Bastard, J.-P., St-Pierre, D. H., Brochu, M., Prud'homme, D., Rabasa-Lhoret, R. (2005). The Metabolically Healthy but Obese Individual Presents a Favorable Inflammation Profile. J. Clin. Endocrinol. Metab. 90: 4145-4150 [Abstract] [Full Text]  
• King, D. E., Mainous, A. G. III, Egan, B. M., Woolson, R. F., Geesey, M. E. (2005). Fiber and C-Reactive Protein in Diabetes, Hypertension, and Obesity. Diabetes Care 28: 1487-1489 [Full Text]  
• Kritchevsky, S. B., Cesari, M., Pahor, M. (2005). Inflammatory markers and cardiovascular health in older adults. Cardiovasc Res 66: 265-275 [Abstract] [Full Text]  
• Nicklas, B. J., You, T., Pahor, M. (2005). Behavioural treatments for chronic systemic inflammation: effects of dietary weight loss and exercise training. CMAJ 172: 1199-1209 [Abstract] [Full Text]  
• (2005). The Latest on Inflammatory Markers and CHD Risk. Journal Watch Cardiology 2005: 4-4 [Full Text]  
• (2005). Inflammation and Vascular Disease: Interesting, but Not Startling, News. JWatch Emergency Med. 2005: 3-3 [Full Text]